What is LOPJLB’s current signal on JUNS?

LOPJLB’s latest quantitative signal on Jupiter Neurosciences, Inc. (JUNS) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is JUNS in?

Jupiter Neurosciences, Inc. (JUNS) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Jupiter Neurosciences, Inc. (JUNS) do?

Jupiter Neurosciences, Inc. is a pharmaceutical company engaged in clinical-stage research and development. Its primary focus is on advancing a resveratrol-based platform product, with the main objective of addressing neuro-inflammation. The company's pipeline includes several drug candidates: JNS101 is undergoing Phase II trials for Friedreich's Ataxia, a rare neurological disorder that damage…

Where is Jupiter Neurosciences, Inc. based / listed?

Jupiter Neurosciences, Inc. is based in US, listed on NASDAQ.

Jupiter Neurosciences, Inc. (JUNS)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.85+2.89%Close

SELLCRISIS · day 73

[SCORES & PROFILE]

FUND: 0
VALUE: 0
GROWTH: 7
GARP: 0
TYPE: Balanced

Composite of Value · Growth · GARP

ROIC-

REV YoY-

ROE-

EPS YoY-

ROA-247.4%

GROSS

-15167

NET

-14220

[VALUATION]

P/E TTM-0.15

P/E FWD-

SECTOR PE20.47

INDUSTRY PE13.95

P/B-4.36

P/FCF-

EV/EBITDA-0.17

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO0.66

ND/EBITDA-

BETA1.88

Jupiter Neurosciences, Inc. (JUNS)

Key stats

Prediction markets

FUNDAMENTALS

Company news